Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269–282. doi:10.1038/nrc.2018.11
   PubMed Web of Science ®Google Scholar
• Cohen EE, LaMonte SJ, Erb NL, et al. American cancer society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016;66(3):203–239. doi:10.3322/caac.21343
   PubMed Web of Science ®Google Scholar
• Hoesli RC, Moyer JS. Immunotherapy for head and neck squamous cell carcinoma. Curr Oral Health Rep. 2016;3(2):74–81. doi:10.1007/s40496-016-0082-2
   PubMedGoogle Scholar
• Liang B, Tao Y, Wang T. Profiles of immune cell infiltration in head and neck squamous carcinoma. Biosci Rep. 2020;40(2):BSR20192724.
   PubMed Web of Science ®Google Scholar
• Bebber CM, Muller F, Prieto Clemente L, Weber J, von Karstedt S. Ferroptosis in cancer cell biology. Cancers. 2020;12(1):164. doi:10.3390/cancers12010164
   PubMed Web of Science ®Google Scholar
• Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging strategies of cancer therapy based on ferroptosis. Adv Mater. 2018;30(12):e1704007.
   PubMed Web of Science ®Google Scholar
• Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130–143. doi:10.1016/j.freeradbiomed.2018.09.043
   PubMed Web of Science ®Google Scholar
• Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34. doi:10.1186/s13045-019-0720-y
   PubMed Web of Science ®Google Scholar
• Lee J, You JH, Shin D, Roh JL. Inhibition of glutaredoxin 5 predisposes cisplatin-resistant head and neck cancer cells to ferroptosis. Theranostics. 2020;10(17):7775–7786. doi:10.7150/thno.46903
   PubMed Web of Science ®Google Scholar
• Shin D, Lee J, You JH, Kim D, Roh JL. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. Redox Biol. 2020;30:101418. doi:10.1016/j.redox.2019.101418
   PubMed Web of Science ®Google Scholar
• Gu W, Kim M, Wang L, Yang Z, Nakajima T, Tsushima Y. Multi-omics analysis of ferroptosis regulation patterns and characterization of tumor microenvironment in patients with oral squamous cell carcinoma. Int J Biol Sci. 2021;17(13):3476–3492. doi:10.7150/ijbs.61441
   PubMed Web of Science ®Google Scholar
• Han F, Li W, Chen T, et al. Ferroptosis-related genes for predicting prognosis of patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2021;278(8):2919–2925. doi:10.1007/s00405-021-06789-3
   PubMed Web of Science ®Google Scholar
• Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford). 2020;2020. doi:10.1093/database/baaa021
   Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22. doi:10.18637/jss.v033.i01
   PubMed Web of Science ®Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–344. doi:10.1111/j.0006-341X.2000.00337.x
   PubMed Web of Science ®Google Scholar
• Nunez E, Steyerberg EW, Nunez J. [Regression modeling strategies]. Rev Esp Cardiol. 2011;64(6):501–507. Spanish. doi:10.1016/j.recesp.2011.01.019
   PubMed Web of Science ®Google Scholar
• Barbie DA, Tamayo P, Boehm JS, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108–112. doi:10.1038/nature08460
   PubMed Web of Science ®Google Scholar
• Byers LA, Diao L, Wang J, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013;19(1):279–290. doi:10.1158/1078-0432.CCR-12-1558
   PubMed Web of Science ®Google Scholar
• Groger CJ, Grubinger M, Waldhor T, Vierlinger K, Mikulits W. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS One. 2012;7(12):e51136. doi:10.1371/journal.pone.0051136
   PubMed Web of Science ®Google Scholar
• Taube JH, Herschkowitz JI, Komurov K, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A. 2010;107(35):15449–15454. doi:10.1073/pnas.1004900107
   PubMed Web of Science ®Google Scholar
• Kazi JU, Ronnstrand L. FMS-like tyrosine kinase 3/FLT3: from basic science to clinical implications. Physiol Rev. 2019;99(3):1433–1466. doi:10.1152/physrev.00029.2018
   PubMed Web of Science ®Google Scholar
• Kang Y, Tiziani S, Park G, Kaul M, Paternostro G. Cellular protection using Flt3 and PI3Kalpha inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity. Nat Commun. 2014;5(1):3672. doi:10.1038/ncomms4672
   PubMed Web of Science ®Google Scholar
• Rossi JF, Lu ZY, Jourdan M, Klein B. Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015;21(6):1248–1257. doi:10.1158/1078-0432.CCR-14-2291
   PubMed Web of Science ®Google Scholar
• Bin S, Xin L, Lin Z, Jinhua Z, Rui G, Xiang Z. Targeting miR-10a-5p/IL-6R axis for reducing IL-6-induced cartilage cell ferroptosis. Exp Mol Pathol. 2021;118:104570. doi:10.1016/j.yexmp.2020.104570
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184. doi:10.1002/hep.28251
   PubMed Web of Science ®Google Scholar
• Taguchi K, Yamamoto M. The KEAP1-NRF2 system in cancer. Front Oncol. 2017;7:85. doi:10.3389/fonc.2017.00085
   PubMed Web of Science ®Google Scholar
• Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:quinone oxidoreductase 1 (NQO1) as a therapeutic and diagnostic target in cancer. J Med Chem. 2018;61(16):6983–7003. doi:10.1021/acs.jmedchem.8b00124
   PubMed Web of Science ®Google Scholar
• Ilangumaran S, Bobbala D, Ramanathan S. SOCS1: regulator of T cells in autoimmunity and cancer. Curr Top Microbiol Immunol. 2017;410:159–189. doi:10.1007/82_2017_63
   PubMed Web of Science ®Google Scholar
• Saint-Germain E, Mignacca L, Vernier M, Bobbala D, Ilangumaran S, Ferbeyre G. SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes. Aging. 2017;9(10):2137–2162. doi:10.18632/aging.101306
   PubMedGoogle Scholar
• Lin RJ, Wu IJ, Hong JY, et al. Capsaicin-induced TRIB3 upregulation promotes apoptosis in cancer cells. Cancer Manag Res. 2018;10:4237–4248. doi:10.2147/CMAR.S162383
   PubMed Web of Science ®Google Scholar
• He F, Chen Z, Deng W, et al. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. Int Immunopharmacol. 2021;98:107789. doi:10.1016/j.intimp.2021.107789
   PubMed Web of Science ®Google Scholar
• Asplund A, Edqvist PH, Schwenk JM, Ponten F. Antibodies for profiling the human proteome-The human protein atlas as a resource for cancer research. Proteomics. 2012;12(13):2067–2077. doi:10.1002/pmic.201100504
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Liang J, Zhi Y, Deng W, et al. Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma. PeerJ. 2021;9:e11627. doi:10.7717/peerj.11627
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang X, Zhang J, Tan J, Li J, Song Z. Development and validation of a combined ferroptosis and immune prognostic classifier for hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:596679. doi:10.3389/fcell.2020.596679
   PubMed Web of Science ®Google Scholar
• Sun J, Yue W, You J, et al. Identification of a novel ferroptosis-related gene prognostic signature in bladder cancer. Front Oncol. 2021;11:730716. doi:10.3389/fonc.2021.730716
   PubMed Web of Science ®Google Scholar
• Zhang A, Yang J, Ma C, Li F, Luo H. Development and validation of a robust ferroptosis-related prognostic signature in lung adenocarcinoma. Front Cell Dev Biol. 2021;9:616271. doi:10.3389/fcell.2021.616271
   PubMed Web of Science ®Google Scholar
• Wang D, Wei G, Ma J, et al. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. BMC Cancer. 2021;21(1):645. doi:10.1186/s12885-021-08341-2
   PubMed Web of Science ®Google Scholar
• Zhang K, Ping L, Du T, et al. A ferroptosis-related lncRNAs signature predicts prognosis and immune microenvironment for breast cancer. Front Mol Biosci. 2021;8:678877.
   PubMed Web of Science ®Google Scholar